REFERENCES
- DeSmet PA, Mohen WA (1996): St. John's wort as an anti-depressant. Brit Med J 313: 241–242.
- Hamilton HB, Hinton DR, Law RE, Gopalakrishna R, Su YZ, Chen ZH, Weiss MH, Couldwell WT (1996): Inhibition of cellular growth and induction of apoptosis in pituitary adenoma cell lines by the protein kinase C inhibitor hypericin: Potential therapeutic application J Neurosurg 85: 329–334.
- Hölzl, Ostrowski E (1987): Johanniskraut (Hypericum per-foratum L.): HPLC analyse der wichtigen Inhalstoffe und deren Variabilitat in einer Population. Dtsch Apoth Ztg 23: 1227–1230.
- Jensen KIN, Gaul SO, Specht EG, Doohon DJ (1995): Hypericin content of Nova Scotia biotypes of Hypericum perforatum L. Can J Plant Sci 75: 923–926.
- Lavie G, Mazur Y, Lavie D, Merulo D (1995): The chemical and biological properties of hypericin —A compound with a broad spectrum of biological activities. Med Res Rev 15 (2): 111–119.
- Linde K, Ramirez G, Mulrow CD, Pauls A, Weiden Hammer W, Melchart D (1996): St. John's wort for depression— An overview and meta-analysis of randomised clinical trials. Brit Med J 313: 253–258.
- Southwell IA, Campbell MH (1991): Hypericin content vari-ation in Hypericum performatum in Australia. Phyto-chemistry 30: 475–478.
- Upton R (1997): St. John's wort — Hypericum perforatum. Herbalgram 40: 1–32.